Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients

NCT02581033 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B.

Interventions

DRUG: Nucleoside Analogue therapy

Sponsor

St Vincent's Hospital Melbourne

Collaborators

[object Object]